Suzuki T, Matsuura K, Suzuki Y, Okumura F, et al. Serum interleukin-6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysis. J Gastroenterol Hepatol 2024 Jun 28. doi: 10.1111/jgh.16672.
PMID: 38943340